We are studying a combination of two medications for patients with non-small cell lung cancer who have had surgery but are not disease-free. The goal is to see if this treatment can help prevent cancer from returning.
Health conditions and diseases that the clinical trial is designed to study and treat.
Resectable Non-small Cell Lung Cancer (NSCLC) is a type of lung cancer that can be surgically removed. It is characterized by abnormal cell growth in the lungs and can lead to symptoms such as persistent cough, chest pain, and difficulty breathing.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.